Archive - March 2020
How UCB Transformed into a More Agile, Data-Driven Organization
£12m committed to preventable disease research
Cediranib trips up in Lynparza combo ovarian cancer trial
Venclyxto gains approval in Europe
“Two-pronged” DNA repair attack could kill drug-resistant cancers
Lilly and AbCellera partner on antibody therapies for COVID-19
FDA green lights study of phage-based drug for resistant infections
FDA okays Roche’s COVID-19 diagnostic test